Organisation paid for research Program year 2025 Source: CMS Open Payments

Socal Research Associates

Neither a doctor nor a teaching hospital

Research payments

$1,027,044

743 payments

Through program year 2025, Socal Research Associates is reported as receiving $1,027,044 in research payments, across 743 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$4,680	3
2024	Research	$35,493	15
2023	Research	$18,233	14
2022	Research	$750	1
2021	Research	$335,318	100
2020	Research	$150,690	72
2019	Research	$481,880	538

Breakdown

Who paid Research payments · program years 2019–2025

Akebia Therapeutics Inc $810,249 584 payments
Retrophin, Inc. $216,045 158 payments
Ardelyx, Inc. $750 1 payment

Studies the money was for Research payments · program years 2019–2025

Akb-6548-Ci-0017 $302,278 370 payments
021Igan17001 $187,938 148 payments
Akb-6548-Ci-0017 $182,759 13 payments
Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (Dd-Ckd) (Inno2vate-Conversion) $62,029 16 payments
Akb-6548-Ci-0016 $61,747 57 payments
Akb-6548-Ci-0014 $47,837 49 payments
Akb-6548-Ci-0016 $46,212 9 payments
Akb-6548-Ci-0015 $25,288 28 payments
Spartacus $24,004 6 payments
Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Correction of Anemia in Subjects With Non-Dialysis-Dependent Chronic Kidney Disease (Ndd-Ckd) (Pro2tect-Correction) $20,006 13 payments

What the money was spent on Research payments · program years 2019–2025

Other $135,822 109 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.